Development of a Biodegradable PLGA Carrier to Provide Wnt Agonists and Antibiotics to Meet the Requirements for Patients with Bone Infections
Authors:
- Song-Shu LinSLSong-Shu Lin
- Shih-Jung LiuShih-Jung Liu
- Err-Cheng ChanECErr-Cheng Chan
- Kowit-Yu ChongKowit-Yu Chong
- Yi-Sheng ChanYCYi-Sheng Chan
- Tsung-Ting TsaiTTTsung-Ting Tsai
- Chi-Chien NiuCNChi-Chien Niu
- Li-Jen YuanLYLi-Jen Yuan
- Chuen-Yung YangCYChuen-Yung Yang
- Hui-Yi HsiaoHHHui-Yi Hsiao
- Yi-Jen HsuehYHYi-Jen Hsueh
- Chung-An ChenCCChung-An Chen
Open Access
- 6 August 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (8) , 1038
Abstract
Antibiotic beads can be used to treat surgical infections. In this study, polylactide–polyglycolide (PLGA) was mixed with vancomycin, the osteogenic enhancer lithium chloride (LiCl), and hot compression to form PLGA-vancomycin-LiCl delivery beads to treat bone infection. An elution method was used to characterize in vitro release characteristics of vancomycin and Li over a 42-day period. The release profiles lasted for more than 42 days for vancomycin and 28 days for Li. The concentration of vancomycin in each sample was well above the breakpoint sensitivity. Lithium cotreatment enhanced the bactericidal effect of vancomycin. Released Li and vancomycin increased the mRNA or protein expressions of osteogenic markers of mesenchymal stem cells (MSCs). In vivo, the PLGA delivery systems were implanted into the distal femoral cavities of rabbits, and the cavity fluid content was aspirated and analyzed at each time point. The released Li and vancomycin lasted more than 6 weeks, and the vancomycin concentrations were much greater than the breakpoint sensitivity. Four rabbits in each group were sacrificed at 8 weeks for histological observation. More mature bone tissue was observed in the Li treatment group. This study provides a PLGA drug delivery system to meet the requirements of patients with bone infections.Keywords
All Related Versions
Funding Information
- National Science Council and Chang Gung Memorial Hospital, Taiwan, Republic of China (CRRPG3H0011~3, CRRPG3K0051~3)
This publication has 34 references indexed in Scilit:
- Lithium chloride stimulates bone formation in extraction socket repair in ratsOral and Maxillofacial Surgery, 2022
- Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophagesJournal of Controlled Release, 2017
- Bioactive glass nanoparticles designed for multiple deliveries of lithium ions and drugs: Curative and restorative bone treatmentEuropean Journal of Pharmaceutical Sciences, 2016
- Polymer degradation and drug delivery in PLGA‐based drug–polymer applications: A review of experiments and theoriesJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2016
- Pathogenesis of Staphylococcus aureus AbscessesThe American Journal of Pathology, 2015
- Electrospun poly(lactic acid-co-glycolic acid) scaffolds for skin tissue engineeringBiomaterials, 2008
- Novel solvent-free fabrication of biodegradable poly-lactic-glycolic acid (PLGA) capsules for antibiotics and rhBMP-2 deliveryInternational Journal of Pharmaceutics, 2007
- Evaluation of whole cells of Bacillus subtilis as substrate for measurement of autolysin activityProcess Biochemistry, 2005
- In vitroelution of vancomycin from biodegradable beadsJournal of Biomedical Materials Research, 1999
- Genotoxicity evaluation of lithium hypochloriteToxicology, 1990